Skip to search boxSkip to navigationSkip to main content

Circulating T cell-monocyte complexes are markers of immune perturbations

  • Julie G. Burel
    ,
  • Mikhail Pomaznoy
    ,
  • Cecilia S.Lindestam Arlehamn
    ,
  • Daniela Weiskopf
    ,
  • Ricardo da Silva Antunes
    ,
  • Yunmin Jung
*Corresponding author for this work
  • Division of Vaccine Discovery La Jolla Institute for Immunology
    ,
  • Division of Inflammation Biology La Jolla Institute for Immunology
    ,
  • LA JOLLA INSTITUTE FOR IMMUNOLOGY
    ,
  • University of Colombo
    ,
  • North Colombo Teaching Hospital
    ,
  • National Institute of Infectious Diseases
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Abstract

<p>Our results highlight for the first time that a significant proportion of cell doublets in flow cytometry, previously believed to be the result of technical artifacts and thus ignored in data acquisition and analysis, are the result of biological interaction between immune cells. In particular, we show that cell:cell doublets pairing a T cell and a monocyte can be directly isolated from human blood, and high resolution microscopy shows polarized distribution of LFA1/ICAM1 in many doublets, suggesting in vivo formation. Intriguingly, T cell-monocyte complex frequency and phenotype fluctuate with the onset of immune perturbations such as infection or immunization, reflecting expected polarization of immune responses. Overall these data suggest that cell doublets reflecting T cell-monocyte in vivo immune interactions can be detected in human blood and that the common approach in flow cytometry to avoid studying cell:cell complexes should be re-visited.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Article number

e46045

Journal (Volume, Issue Number)

eLife (Volume 8)

Publication milestones

  • Published - 2019

Publication status

Published - 2019

ISSN

2050-084X

Publication IDs

  • Scopus: 85068748226
  • PubMed: 31237234
  • Scopus: 85071891394

Publication metrics

Metrics

Fractional count
1
Fractional count
0.04
Fractional count
23
Fractional count
0.96
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
56
Captures
187
Mentions
6

Funding Details

We thank Dr Chery Kim and all present and past members at the flow cytometry core facility at the La Jolla Institute for Immunology for assistance in cell sorting and technical discussion. We thank Dr Zbigniew Mikulski from the microscopy core at the La Jolla Institute for Immunology for assistance and technical advice on microscopy imaging. We thank Yoav Altman at the Sanford Burnham Prebys flow cytometry core for technical assistance with imaging flow cytometry. We thank Dr Joe Trotter from the R and D Advanced Technology Group at BD Biosciences for useful technical discussion about cytometry instrument fluidic systems. Research reported in this manuscript was supported by the National Institute of Allergy and Infectious Diseases division of the National Institutes of Health under award number U19AI118626, R01AI137681, HHSN272201400045C, P01HL078784, S10OD021831 and S10OD016262. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Imaging flow cytometry was supported by the James B Pendleton Charitable trust. Human subjects: Ethical approval to carry out this work is maintained through the La Jolla Institute for Allergy and Immunology Institutional Review Board (protocols VD-143, VD-085, VD-090), the Medical Faculty of the University of Colombo (which served as a National Institutes of Health-approved institutional review board for Genetech, protocols EC-15-094, EC-15-002, EC.15.095), and the Johns Hopkins School of Public Health Institutional Review Board (RHG holds dual appointment at UPCH and JHU; protocol 00003804). All clinical investigations have been conducted according to the principles expressed in the Declaration of Helsinki. All participants, except anonymously recruited blood bank donors in Sri Lanka, provided written informed consent prior to participation in the study.
FundersFunding numbers
La Jolla Institute for Allergy and Immunology Institutional Review Board
VD-143, VD-085, VD-090
Medical Faculty of the University of Colombo
-
National Institutes of Health-approved
EC-15-094, EC-15-002, EC.15.095
UPCH
-
NIH
S10OD021831, S10OD016262, P01HL078784, HHSN272201400045C, R01AI137681, U19AI118626
FNIH
-
NIAID
-
JHU
00003804
JHSPH
-
James B. Pendleton Charitable Trust
-